SSY GROUP(02005): Nifedipine hydrochloride has been approved by the National Medical Products Administration for registration as an active pharmaceutical ingredient for use in marketed formulations.

05/03/2025

GMT Eight

SSY GROUP (02005) announced that the group's Nicardipine Hydrochloride has been approved for registration by the China National Medical Products Administration as an active pharmaceutical ingredient for use in marketed preparations. Nicardipine Hydrochloride is mainly used for the treatment of high blood pressure.

ANTENGENE-B(06996): The new drug market application of Xevor has been approved by the Indonesian Food and Drug Administration.

Malaysia invests $2.5 billion to purchase Arm technology to promote the upgrading of the domestic semiconductor industry.

Contact: contact@gmteight.com

SSY GROUP(02005): Nifedipine hydrochloride has been approved by the National Medical Products Administration for registration as an active pharmaceutical ingredient for use in marketed formulations.

RECOMMEND

US Stock Market Move | KINGSOFT CLOUD (KC.US) rose by 11%, Lyon expects the company GenAI's revenue to increase by 60% this year.

The U.S. February PMI composite index exceeds expectations with non-manufacturing PMI strengthening.

US Stock Market Move | China Yuchai International Limited (CYD.US) rose nearly 10% as engine sales in the second half of 2024 showed a significant growth of 10.9%.